BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 119889
Published online Sep 15, 2026. doi: 10.4251/wjgo.119889
Table 1 Baseline demographic and clinical characteristics of the study population, n (%)
Characteristics
Total cohort (n = 383)
Beijing Friendship Hospital (n = 302)
Beijing Tiantan Hospital (n = 81)
Age (years), mean ± SD66.7 ± 12.567.2 ± 12.264.8 ± 13.1
Gender
    Male202 (52.7)162 (53.6)40 (49.4)
    Female181 (47.3)140 (46.4)41 (50.6)
Class distribution
Cancerous225 (58.7)181 (59.9)44 (54.3)
Noncancerous158 (41.3)121 (40.1)37 (45.7)
Lesion subtypes
Cancerous group
    Pancreatic ductal adenocarcinoma219 (57.2)176 (58.3)43 (53.1)
    Pancreatic acinar cell carcinoma6 (1.6)5 (1.7)1 (1.2)
Noncancerous group
    Solid pseudopapillaryoma72 (18.8)56 (18.5)16 (19.8)
    Autoimmune pancreatitis55 (14.4)41 (13.6)14 (17.3)
    Neuroendocrine neoplasms31 (8.1)24 (7.9)7 (8.6)
Table 2 Dual-center energy statistics for the two hospitals
Center
Mean
SD
Min
Max
Center A_00.0614740.0562340.0087410.559571
Center A_10.0478960.0400440.0091320.320019
Center B_00.0212910.0092370.0075140.047186
Center B_10.0236280.0172170.0093670.120883
Table 3 Internal validation results
Methods
Precision (%) (95%CI)↑
Sensitivity (%) (95%CI)↑
Accuracy (%) (95%CI)↑
Specificity (%) (95%CI)↑
F1 score (%) (95%CI)↑
ResNet-50a86.96 (82.17-90.95)94.14 (91.47-97.49)89.12 (86.41-92.05)82.76 (77.43-88.30)90.50 (87.76-93.16)
Swin_transformera89.29 (83.64-92.31)94.34 (90.48-96.97)90.53 (86.92-92.82)85.71 (79.89-90.64)91.74 (88.02-93.65)
MedViTV2a90.09 (85.32-93.24)95.24 (91.54-97.66)91.50 (87.95-93.85)86.75 (81.71-91.33)92.59 (89.20-94.48)
MCEUS-C2Net (ours)93.46 (89.08-95.97)97.09 (95.48-99.51)94.51 (92.31-96.67)91.14 (86.70-94.92)95.24 (93.01-97.01)
Table 4 External validation results
Methods
Precision (%) (95%CI)↑
Sensitivity (%) (95%CI)↑
Accuracy (%) (95%CI)↑
Specificity (%) (95%CI)↑
F1 score (%) (95%CI)↑
ResNet-50b84.57 (79.00-89.88)74.00 (67.88-80.49)78.65 (74.32-82.97)84.12 (78.31-89.51)78.93 (74.13-83.42)
Swin_transformerb86.63 (81.87-91.24)81.00 (75.26-86.26)82.97 (78.92-86.49)85.29 (79.88-90.30)83.72 (79.49-87.35)
MedViTV2a86.57 (82.03-91.35)87.00 (82.16-91.67)85.68 (82.16-89.19)84.12 (78.33-89.54)86.78 (83.24-90.10)
MCEUS-C2Net (ours)91.88 (87.75-95.26)90.50 (86.47-94.23)90.59 (87.84-93.51)90.59 (85.98-94.51)91.18 (88.32-93.77)
Table 5 Ablation study results on the internal validation set
Methods
Precision (%) (95%CI)↑
Sensitivity (%) (95%CI)↑
Accuracy (%) (95%CI)↑
Specificity (%) (95%CI)↑
F1 score (%) (95%CI)↑
GFEb86.85 (82.25-91.39)88.10 (83.76-92.56)86.41 (82.82-89.74)84.44 (79.28-89.64)87.47 (83.99-90.70)
LFEb88.73 (84.46-92.72)90.00 (85.92-93.97)88.46 (85.13-91.54)86.67 (81.82-91.33)89.36 (86.15-92.38)
LFE + CSAb90.05 (85.86-93.91)90.48 (86.57-94.45)89.49 (86.41-92.56)88.33 (83.60-92.90)90.26 (87.12-93.15)
LFE + GFEa90.09 (85.32-93.24)95.24 (91.54-97.66)91.50 (87.95-93.85)86.75 (81.71-91.33)92.59 (89.20-94.48)
MCEUS-C2Net (ours)93.46 (89.08-95.97)97.09 (95.48-99.51)94.51 (92.31-96.67)91.14 (86.70-94.92)95.24 (93.01-97.01)
Table 6 Ablation study results on the external validation set
Methods
Precision (%) (95%CI)↑
Sensitivity (%) (95%CI)↑
Accuracy (%) (95%CI)↑
Specificity (%) (95%CI)↑
F1 score (%) (95%CI)↑
GFEb83.62 (78.15-89.10)74.00 (67.88-80.49)78.11 (73.78-82.43)82.94 (77.06-88.54)78.51 (73.63-82.95)
LFEb86.71 (81.39-92.03)75.00 (68.93-81.42)80.27 (75.95-84.32)86.47 (81.03-91.47)80.43 (75.80-84.85)
LFE + CSAb87.10 (82.18-92.19)81.00 (75.50-86.46)83.24 (79.18-87.30)85.88 (80.46-91.14)83.94 (79.77-87.77)
LFE + GFEa86.57 (82.03-91.35)87.00 (82.16-91.67)85.68 (82.16-89.19)84.12 (78.33-89.54)86.78 (83.24-90.10)
MCEUS-C2Net (ours)91.88 (87.75-95.26)90.50 (86.47-94.23)90.59 (87.84-93.51)90.59 (85.98-94.51)91.18 (88.32-93.77)


Write to the Help Desk